Iranian Journal of Immunology

Prognostic Value of HLA-G in Malignant Liver and Pancreas Lesions

Document Type : Original Article

Authors

Parisa Khodabandeh Shahraki 1
Yasmin Zare 1
Negar Azarpira 2
Massood Hosseinzadeh 3
Shirin Farjadian 1

1 Department of Immunology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran

2 Organ Transplant Research Center, Shiraz University of Medical Sciences, Shiraz, Iran

3 Department of Pathology, Shiraz University of Medical Sciences, Shiraz, Iran

https://doi.org/10.22034/iji.2018.39338
Abstract
Background: Human leukocyte antigen (HLA)-G is a nonclassical HLA class I molecule with modulatory effects on NK and T cells. Because HLA-G expression is frequently detected in different solid tumors, it may be involved in tumor immune evasion. Objective: This study was designed to elucidate the prognostic value of HLA-G in hepatocellular carcinoma (HCC) and pancreatic adenocarcinoma (PADC). The influence of hepatitis B virus (HBV) infection on HLA-G expression was also evaluated in patients with HCC. Methods: HLA-G expression was investigated in tumor tissues from patients with HCC (n=74) or PADC (n=42) with immunohistochemical techniques. The presence of HBV genome was also examined in HCC tumor tissues by PCR. Results: HLA-G expression was detected in 66% of PADC and in 31% of HCC samples. In contrast to HCC, HLA-G overexpression was associated with advanced stages and grades in PADC. HBV genome was detected in 31% of HCC samples but we found no correlation between HLA-G expression and the presence of HBV genome in these tumors. Conclusion: Our findings showed that HLA-G overexpression in tumor tissue correlated with poor prognosis in PADC. HLA-G expression is apparently affected by the patient’s genetic background and other epigenetic factors rather than by HBV infection.
Iranian Journal of Immunology
Volume 15, Issue 1
Winter 2018
Pages 28-37

Home

Guide for Authors

Submit Manuscript

Guide for Reviewers

Contact Us